← Back to headlines
ImmunityBio Secures $75M Financing from Oberland
ImmunityBio has successfully secured $75 million in financing as part of a deal with Oberland Capital.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
